Trial Profile
Effects Of Candesartan Cilexetil vs Standard Therapy on Serum Levels of Brain Natriuretic Peptide in Patients Suffering From Chronic Heart Failure With Depressed and Preserved Systolic Function.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil (Primary) ; Heart failure therapies
- Indications Chronic heart failure
- Focus Therapeutic Use
- Acronyms CANDHEART
- Sponsors Takeda Italia Farmaceutici
- 18 Feb 2009 New trial record